These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 33333002)

  • 1. Buyer beware: inflated claims of sensitivity for rapid COVID-19 tests.
    Fitzpatrick MC; Pandey A; Wells CR; Sah P; Galvani AP
    Lancet; 2021 Jan; 397(10268):24-25. PubMed ID: 33333002
    [No Abstract]   [Full Text] [Related]  

  • 2. Saliva Tests Comparable With Nasal Swabs for SARS-CoV-2 Detection.
    Abbasi J
    JAMA; 2021 Mar; 325(10):924. PubMed ID: 33687449
    [No Abstract]   [Full Text] [Related]  

  • 3. Strengths and weakness of diagnostic tests of SARS CoV-2 infection.
    Hernández-Pérez JM; Martín-González E; Pino-Yanes M
    Med Clin (Barc); 2020 Nov; 155(10):464-465. PubMed ID: 32546315
    [No Abstract]   [Full Text] [Related]  

  • 4. Saliva-based testing for diagnosis of SARS-CoV-2 infection: A meta-analysis.
    Kivelä JM; Jarva H; Lappalainen M; Kurkela S
    J Med Virol; 2021 Mar; 93(3):1256-1258. PubMed ID: 33079392
    [No Abstract]   [Full Text] [Related]  

  • 5. Combined Self-Collected Anterior Nasal and Oropharyngeal Specimens versus Provider-Collected Nasopharyngeal Swabs for the Detection of SARS-CoV-2.
    Shakir SM; Barker AP; Hillyard DR; Gilmore N; Barrett JW; Orlandi RR; Hanson KE
    J Clin Microbiol; 2020 Dec; 59(1):. PubMed ID: 33087437
    [No Abstract]   [Full Text] [Related]  

  • 6. [SARS-CoV-2 Testing in Cadavers: The Experience of the Southern Portugal Delegation of the National Institute of Forensic Medicine and Forensic Sciences].
    Logrado D; Inácio AR; Amorim A; Dos Santos C; Cunha E
    Acta Med Port; 2020 Dec; 33(12):858. PubMed ID: 33496257
    [No Abstract]   [Full Text] [Related]  

  • 7. How to use imperfect tests for COVID-19 (SARS-CoV-2) to make clinical decisions.
    Bell KJ; Stanaway FF; Irwig LM; Horvath AR; Teixeira-Pinto A; Loy C
    Med J Aust; 2021 Feb; 214(2):69-73.e1. PubMed ID: 33415725
    [No Abstract]   [Full Text] [Related]  

  • 8. SARS-CoV-2 diagnostics: Some reflections on current assays.
    Antonelli G; Stefani S; Pistello M
    Diagn Microbiol Infect Dis; 2021 Feb; 99(2):115237. PubMed ID: 33130508
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparison of 4 molecular assays for detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
    Uprety P; Mathew J; Weinstein MP; Kirn TJ
    Diagn Microbiol Infect Dis; 2021 Feb; 99(2):115196. PubMed ID: 33220615
    [No Abstract]   [Full Text] [Related]  

  • 10. Mass testing for covid-19 in the UK.
    Gill M; Gray M
    BMJ; 2020 Nov; 371():m4436. PubMed ID: 33199289
    [No Abstract]   [Full Text] [Related]  

  • 11. COVID-19 Testing Tests Our Mettle.
    Hefferon KL; St Juliana JR; Miller HI
    Mo Med; 2020; 117(5):417-420. PubMed ID: 33311741
    [No Abstract]   [Full Text] [Related]  

  • 12. Inhale, then exhale: start afresh to diagnose Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) by non-invasive face-mask sampling technique.
    Kanaujia R; Biswal M; Angrup A; Ray P
    Clin Microbiol Infect; 2020 Dec; 26(12):1701-1702. PubMed ID: 32629023
    [No Abstract]   [Full Text] [Related]  

  • 13. Identifying SARS-CoV-2 infections in South Africa: Balancing public health imperatives with saving lives.
    Baxter C; Abdool Karim Q; Abdool Karim SS
    Biochem Biophys Res Commun; 2021 Jan; 538():221-225. PubMed ID: 33143875
    [No Abstract]   [Full Text] [Related]  

  • 14. Romeo and Juliet: Revisited (at the time of COVID-19).
    Costantino G; Peyvandi F; Montano N; Agostoni C
    Eur J Intern Med; 2020 Nov; 81():94. PubMed ID: 32653154
    [No Abstract]   [Full Text] [Related]  

  • 15. Proactive screening approach for SARS-CoV-2 among healthcare workers.
    Oster Y; Wolf DG; Olshtain-Pops K; Rotstein Z; Schwartz C; Benenson S
    Clin Microbiol Infect; 2021 Jan; 27(1):155-156. PubMed ID: 32822884
    [No Abstract]   [Full Text] [Related]  

  • 16. Histopathological findings in COVID-19-induced cutaneous lesions. Clinicopathological correlation of SARS-CoV-19 dermatologic patterns: review of the literature.
    Nieto-Benito LM; Hernández de la Torre-Ruiz E; Balaguer-Franch I; Rosell-Díaz ÁM; Mateos-Mayo A; Herrero-Sanchez A; Lacasta-Plasín C; García-Piqueras P; Barchino-Ortiz L; Bergón-Sendín M; Pulido-Pérez A; Baniandrés-Rodríguez O; Rodriguez-Lomba E; Molina-Lopez I; Suárez-Fernandez R
    Australas J Dermatol; 2021 Feb; 62(1):e98-e101. PubMed ID: 32920868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The pitfalls of preventive testing for SARS-CoV-2].
    Wismans LV; Fanoy EB; van Eijck CHJ; van der Eijk AA
    Ned Tijdschr Geneeskd; 2020 Dec; 165():. PubMed ID: 33332034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluating the newly developed BioFire COVID-19 test for SARS-CoV-2 molecular detection.
    Liotti FM; Menchinelli G; Marchetti S; Morandotti GA; Sanguinetti M; Posteraro B; Cattani P
    Clin Microbiol Infect; 2020 Dec; 26(12):1699-1700. PubMed ID: 32735938
    [No Abstract]   [Full Text] [Related]  

  • 19. Pooling samples: a testing option for SARS-CoV-2 during a supply shortage.
    Salimnia H; Mitchell R; Gundel A; Cambell A; Gammou F; Chopra T; Fairfax M
    Diagn Microbiol Infect Dis; 2021 Jan; 99(1):115205. PubMed ID: 33190092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid Response to an Outbreak in Qingdao, China.
    Xing Y; Wong GWK; Ni W; Hu X; Xing Q
    N Engl J Med; 2020 Dec; 383(23):e129. PubMed ID: 33207089
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.